Nourish Raises $100M to Expand GLP-1 Weight Loss Support Program
Nourish just raised 100 million dollars in its latest funding round. Menlo Ventures led the investment. Now, the company…
-
-
Novo Nordisk Draws Contrarian Support Over Eli Lilly as GLP-1 Valuation Gap Widens
Investors are taking a fresh look at the top companies making weight-loss drugs. A recent panel on CNBC suggested…
-
LifeMD Adds Daily GLP-1 Pill Orforglipron After FDA Nod
LifeMD recently announced the addition of orforglipron to its comprehensive weight management program. Eli Lilly and Company developed this…
-
Foundayo (Orforglipron): FDA Approves First Once-Daily GLP-1 Pill for Weight Loss
The FDA’s recent approval of Foundayo (orforglipron) is a genuine turning point for anyone who has struggled with weight…
-
The Systematic Expansion of GLP-1 Therapies in Modern Medicine: From Glycemic Control to Multi-Organ Protection
To begin with, GLP-1 drugs are fundamentally changing how we treat chronic diseases. Initially, these medicines primarily helped manage…
-
GLP-1 Pill vs Injection: Which Is Better for Weight Loss?
Glucagon-like peptide-1 (GLP-1) receptor agonists have fundamentally changed how doctors treat obesity and type 2 diabetes. Regulatory approvals for…
-
GLP-1 Pills for Everyone? What Normal Weight Users Need to Know
Weight loss drugs like Wegovy and Ozempic have changed how doctors treat obesity and diabetes. These medications work incredibly…
-
Novo Nordisk and Hims & Hers Reach Distribution Agreement for Wegovy and Ozempic, Ending Patent Litigation
Novo Nordisk and the health site Hims & Hers just signed a major deal. This new partnership lets people…
-
From Ozempic to Oral Pills: The New Breakthrough in Weight Loss Medicine
GLP-1 drugs have changed the conversation around weight loss and blood sugar control in the US, but most of…
-
Are GLP-1 Pills Safe Long-Term?
Starting a treatment journey with GLP-1 pills marks a major milestone in managing metabolic health. These medications originally required…
